JPRN-jRCT2080221598未知4 期
A Phase IV, Multi-centre, Randomised, Double-Blind Study to Evaluate the Efficacy and Safety of NK- 104 versus Atorvastatin in Chinese Patients with Hypercholesterolaemia
试验速览
- 阶段
- 4 期
- 入组人数
- 480
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Patients diagnosed with hypercholesterolaemia
排除标准
- •1.Any conditions which may cause secondary dyslipidemia
- •2.Uncontrolled diabetes mellitus
- •3.Any surgical or medical condition which might significantly alter the absorption, distribution, metabolism, or excretion of any drug
研究者
相似试验
进行中（未招募）
不适用
A clinical study to compare the effectiveness and safety of the combination of lenalidomide, melphalan and prednisone with placebo, melphalan and prednisone in newly diagnosed Multiple Myeloma patients who are 65 years or older.MedDRA version: 14.1Level: PTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Multiple MyelomaEUCTR2006-001865-41-NLCelgene International Sàrl450
进行中（未招募）
1 期
A Trial to Assess the Safety and Efficacy of Emactuzumab versus Placebo in Patients with Giant Cell Tumours.Tenosynovial Giant Cell TumourMedDRA version: 21.1Level: LLTClassification code 10025564Term: Malignant giant cell tumorSystem Organ Class: 100000004864EUCTR2021-001716-29-BESynOx Therapeutics Ltd160
已完成
3 期
Study to Compare Intravenous Ceftaroline Fosamil Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients with Community-Acquired Bacterial PneumoniaCTRI/2011/10/002053AstraZeneca AB Sweden692
进行中（未招募）
1 期
A Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled, 3-Arm Parallel Group Study to Determine the Efficacy and Safety of Lenalidomide (Revlimid) in Combination with Melphalan and Prednisone Versus Placebo Plus Melphalan and Prednisone in Subjects with Newly Diagnosed Multiple Myeloma Who Are 65 Years of Age or OlderMedDRA version: 8.1Level: LLTClassification code 10028228Term: Multiple myelomaMultiple MyelomaEUCTR2006-001865-41-FRCelgene International Sàrl450
进行中（未招募）
不适用
Evaluation of Ceftaroline Fosamil versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.complicated bacterial skin and soft tissue infectionsMedDRA version: 14.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-004013-16-BEAstraZeneca AB765